EHGO
EShallGo Inc.
$2.08
▼ -22.10%$2.08▼ -84.88%
over 1Y
L $1.29H $13.76
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-22.1%
1W-54.5%
1M+14.3%
3M-40.4%
YTD-41.7%
1Y-84.9%
Avoid
Conviction
Horizon
Medium (3–12mo)
Conservative balance sheet (liabilities/equity 0.79x); but revenue fell -19.1% YoY.
Revenue (FY2025) $11.0M · FY2025
EShallGo Inc. shows $11.0M in FY2025 revenue (-19.1% YoY), a -98.0% net margin, and -103.1% ROE.
Supporting the case: conservative balance sheet (liabilities/equity 0.79x).
Is EHGO a buy? The one-page verdict, explained →
The options angle
model · matches our verdictBear put spread (caution)~60d expiry
- Long put 2 @ ~1.28 est
- Short put 2 @ ~1.28 est
debit $0max +$0max $0
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
| Line item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | $18.3M | $15.1M | $13.6M | $11.0M |
| Gross profit | $7.62M | $4.70M | $4.57M | $3.10M |
| Operating income | $2.95M | $1.32M | $910K | -$10.1M |
| Net income | $1.83M | $478K | $8.65K | -$10.8M |
| Diluted EPS | $0.09 | $0.02 | $0.00 | -$0.49 |
| Net margin | 10.0% | 3.2% | 0.1% | -98.0% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value-$2.87M
EV / EBITDA—
EV / Sales-0.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-235.3%
FCF yield-30.1%
Quality & risk
ROIC (est.)-74.9%
Free cash flow-$1.38M
Total debt$146K
Net cash$7.45M
Altman Z-Score-0.00 distress
Piotroski F-Score1/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+8.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗6-KPeriod ending 2026-07-012026-07-01open ↗424B5Filing2026-07-01open ↗6-KPeriod ending 2026-06-252026-06-25open ↗424B5Filing2026-06-25open ↗F-1/AFiling2026-06-17open ↗F-1Filing2026-06-08open ↗DRSFiling2026-05-26open ↗6-KPeriod ending 2026-05-122026-05-12open ↗6-KPeriod ending 2026-05-052026-05-05open ↗6-KPeriod ending 2026-04-242026-04-24open ↗6-KPeriod ending 2026-04-222026-04-22open ↗6-KPeriod ending 2026-04-162026-04-16open ↗
Frequently asked
- Is EShallGo Inc. (EHGO) a buy?
- EHGO currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.79x); but revenue fell -19.1% YoY.
- What is EShallGo Inc.'s quality score?
- EHGO scores 40.08557353746756/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001879754, latest 6-K filed 2026-07-01) · EODHD · as of 7/5/2026, 7:08:41 AM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 5, 2026, 3:08 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.